Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
TGF‐β signaling and the fibrotic response
2.266
Zitationen
2
Autoren
2004
Jahr
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor-beta (TGF-beta), connective tissue growth factor (CTGF, CCN2), and ED-A fibronectin (ED-A FN) and the antifibrotic proteins tumor necrosis factor-alpha (TNF-alpha) and gamma-interferon (IFN-gamma).
Ähnliche Arbeiten
Transforming Growth Factor β in Tissue Fibrosis
1994 · 3.068 Zit.
A multigenic program mediating breast cancer metastasis to bone
2003 · 2.589 Zit.
Role of Transforming Growth Factor β in Human Disease
2000 · 2.413 Zit.
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 · 2.368 Zit.
The biology of platelet-derived growth factor
1986 · 2.020 Zit.